T. DEMIRER Et Al. , "HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY," JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.3, pp.596-602, 1995
DEMIRER, T. Et Al. 1995. HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY. JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.3 , 596-602.
DEMIRER, T., WEAVER, C., BUCKNER, C., PETERSEN, F., BENSINGER, W., SANDERS, J., ... CLIFT, R.(1995). HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY. JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.3, 596-602.
DEMIRER, TANER Et Al. "HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY," JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.3, 596-602, 1995
DEMIRER, TANER Et Al. "HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY." JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.3, pp.596-602, 1995
DEMIRER, T. Et Al. (1995) . "HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY." JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.3, pp.596-602.
@article{article, author={TANER DEMİRER Et Al. }, title={HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=1995, pages={596-602} }